Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1104798

registered interest
date	25/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans the Government and NHS England have to ensure that CCGs use the funding allocated nationally to prescribe Flash Glucose Monitoring from 1 April 2019 using central NHS criteria.
tabling member constituency	Wakefield
tabling member printed	Mary Creagh
uin	236412
answer	answer is ministerial correction date of answer 29/03/2019 answer text <p>In November 2018, NHS England announced action to end the current variation in accessing flash glucose monitors. From April 2019 there will be a more consistent national approach to making these devices available. Clinical commissioning groups (CCGs) will be reimbursed to cover the costs of flash glucose monitoring sensors for those type 1 diabetes patients who are most likely to benefit from their use. NHS England has published detailed criteria and supporting guidance at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding.pdf</a></p><p> </p><p>CCGs will be reimbursed for the cost of flash glucose monitoring sensors for those who meet these criteria, which could amount to up to 20% of their type 1 diabetes populations. CCGs can also locally choose to fund flash glucose monitoring for other patients with diabetes. The guidance advises that as part of their annual review process, patients with diabetes should be assessed for suitability for flash glucose monitoring. This process can also form part of a review for a different purpose, if that occurs earlier. This will promote a systematic approach to increasing take up.</p><p> </p><p>NHS England has engaged with NHS Clinical Commissioners, the membership organisation for CCGs, regarding the planned arrangements so that they can advise their members as appropriate. An FAQ for patients and commissioners is also being prepared and will be published, to aid the implementation. NHS England is also in conversations with the Academic Health Science Network to identify the capacity and scope for them to aid in rolling out flash glucose monitoring.</p><p> </p><p>Due to the limitations of the data collected by the NHS Business Services Authority, it is not possible to conclusively state which CCGs do or do not currently prescribe flash glucose monitors.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 236413 236414 question first answered 29/03/2019 14:47:45 answering member 4008 label Biography information for Dame Caroline Dinenage previous answer version 110760 answering member constituency Gosport answering member printed Caroline Dinenage answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1579 label Biography information for Mary Creagh

1091258

registered interest
date	19/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the (a) number and (b) percentage of people diagnosed with type 1 diabetes who have access to insulin pumps funded by the NHS.
tabling member constituency	South Holland and The Deepings
tabling member printed	Sir John Hayes
uin	234083
answer	answer is ministerial correction date of answer 27/03/2019 answer text <p>The information requested is not centrally held.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 27/03/2019 12:48:15 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	350 label Biography information for Sir John Hayes

1091259

registered interest
date	19/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure his Department is (a) aware of new technologies for diabetes treatment and (b) enables the timely (i) funding and (ii) adoption of those technologies.
tabling member constituency	South Holland and The Deepings
tabling member printed	Sir John Hayes
uin	234084
answer	answer is ministerial correction date of answer 27/03/2019 answer text <p>In the NHS Long Term Plan, NHS England committed to both improving the pipeline of innovation and speeding up the uptake and spread, so that proven and affordable innovations get to patients faster. This will include setting up a new advisory service for innovators, linked to the Academic Health Science Networks and bringing together in one place all ‘horizon-scanning’ activities. The uptake of proven, affordable innovations will be accelerated through a new Medtech funding mandate for health technology products which have been assessed as cost saving by the National Institute for Health and Care Excellence.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 27/03/2019 15:46:20 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	350 label Biography information for Sir John Hayes

1083525

registered interest
date	07/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps he has taken to widen access to blood glucose monitoring technology for diabetes patients.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	229721
answer	answer is ministerial correction date of answer 15/03/2019 answer text <p>Glucose monitoring technology, such as continuous glucose monitoring or blood glucose test strips, will continue to be available to those meeting the relevant clinical criteria.</p><p> </p><p>In November 2018, NHS England announced that it will ensure that flash glucose monitoring is available on prescription for all patients who qualify for it in line with current recommendations. From April 2019, all qualifying patients will be able to receive it from their local general practitioner or diabetes team.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/03/2019 12:24:05 answering member 4067 label Biography information for Steve Brine
tabling member	4079 label Biography information for Julian Sturdy

1055922

registered interest
date	06/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to his Answer of 5 February 2019 to Question 213249 on Diabetes: Medical Equipment, what role integrated care systems will play in ensuring that people with diabetes are able to access their preferred glucose meter.
tabling member constituency	Knowsley
tabling member printed	Mr George Howarth
uin	217483
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>Integrated care systems (ICSs) are partnerships made of National Health Service organisations, local councils and others to take collective responsibility for managing resources, delivering NHS standards, and improving the health of the population they serve. Clinical commissioning groups (CCGs) are central partners in ICSs. CCGs will continue to be responsible for making commissioning decisions in an ICS. We expect that, working with their partners in an ICS, CCGs will continue to support people with diabetes to access their preferred glucose monitoring device in line with best practice clinical guidance.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/02/2019 17:24:12 answering member 4067 label Biography information for Steve Brine
tabling member	481 label Biography information for Sir George Howarth

1051478

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many Abbott FreeStyle Libre flash glucose monitoring devices and sensors local clinical commissioning groups prescribed in (a) 2017-18 (b) 2018-19 to date.
tabling member constituency	Leicester East
tabling member printed	Keith Vaz
uin	214470
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>The NHS Business Services Authority does not hold data for FreeStyle Libre flash glucose monitoring devices. However, prescription data for FreeStyle Libre Sensors prescribed in clinical commissioning groups in the financial years 2017/18 and 2018/19 to date can be found in the attached table.</p><p> </p><p>This data refers to FreeStyle Libre Sensor packs that include one sensor, one sensor applicator, and one wipe.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 13:55:36 answering member 4067 label Biography information for Steve Brine attachment 1 file name PQ214470 Data Completed.xlsx title PQ214470 attached data
tabling member	338 label Biography information for Keith Vaz

1051482

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the average length of time taken is for the FreeStyle Libre sensors to be issued to people with diabetes through the NHS.
tabling member constituency	Leicester East
tabling member printed	Keith Vaz
uin	214471
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>The information requested is not centrally held.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 13:44:20 answering member 4067 label Biography information for Steve Brine
tabling member	338 label Biography information for Keith Vaz

1051483

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what is the cost to the NHS is of each FreeStyle Libre flash glucose monitoring device.
tabling member constituency	Leicester East
tabling member printed	Keith Vaz
uin	214472
answer	answer is ministerial correction date of answer 08/02/2019 answer text <p>The cost of 1 FreeStyle Libre sensor, 1 sensor applicator, and 1 wipe is £35 as listed in the February 2019 Drug Tariff.</p><p> </p><p>Net Ingredient Cost is the basic price of a drug as stated in Part II Clause 8 of the Drug Tariff.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/02/2019 12:32:42 answering member 4067 label Biography information for Steve Brine
tabling member	338 label Biography information for Keith Vaz

1051485

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what representations his Department has made to the pharmaceutical company Abbott on the availability of FreeStyle Libre being issued to people with Type 1 diabetes from April 2019.
tabling member constituency	Leicester East
tabling member printed	Keith Vaz
uin	214473
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>On 14 November 2018, it was announced that flash glucose monitors will be available on prescription for every patient who qualifies for them, in line with National Health Service clinical guidelines.</p><p> </p><p>The Department has not made any representations to Abbott since.</p><p> </p><p>Clinical commissioning groups (CCGs) are responsible for commissioning diabetes services. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population, are based on the available evidence, and take into account national guidelines. This should include consideration of access to diabetes technologies such as FreeStyle Libre.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:18:43 answering member 4067 label Biography information for Steve Brine
tabling member	338 label Biography information for Keith Vaz

1051962

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the announcement in November 2018 that they intend to centrally fund Freestyle Libre glucose flash monitors, what plans they have to widen access to other diabetes technologies.
tabling member printed	Lord Morris of Aberavon
uin	HL13294
answer	answer is ministerial correction date of answer 13/02/2019 answer text <p>A range of diabetes technologies and methods of glucose monitoring, such as continuous glucose monitoring or blood glucose test strips, will continue to be available to those meeting the relevant clinical criteria.</p><p>One of the long standing and fundamental principles of the National Health Service is that the best way to address local challenges is through clinically-led decision-making, as close to patients as possible.</p><p>Clinical commissioning groups (CCGs) are responsible for commissioning diabetes services. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population, are based on the available evidence, and take into account national guidelines. This should include consideration of access to diabetes technologies such as FreeStyle Libre.</p> answering member printed Baroness Blackwood of North Oxford question first answered 13/02/2019 11:53:44 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	565 label Biography information for Lord Morris of Aberavon